MicroRNAs: Turning the Tide in Testicular Cancer

Nirmish Singla, John T. Lafin, Aditya Bagrodia

Research output: Contribution to journalEditorialpeer-review

22 Scopus citations


MicroRNAs are poised to radically change the way we care for patients with germ cell tumors (GCTs) across all disease states, from diagnosis to managing chemorefractory disease. miR-371a-3p is a promising candidate biomarker that may precisely individualize GCT treatment paradigms.

Original languageEnglish (US)
Pages (from-to)541-542
Number of pages2
JournalEuropean urology
Issue number5
StatePublished - Nov 2019

ASJC Scopus subject areas

  • Urology


Dive into the research topics of 'MicroRNAs: Turning the Tide in Testicular Cancer'. Together they form a unique fingerprint.

Cite this